Research output per year
Research output per year
Search results
-
2019
Cerliponase alfa for the treatment of neuronal ceroid lipofuscinosis type 2 (CLN2)
Walton, M. J., O'Connor, J., Meader, N., Claxton, L., Harden, M., Woolacott, N. F. & Hodgson, R., 27 Nov 2019, National Institute for Health and Care Excellence.Research output: Book/Report › Commissioned report
-
Letermovir for the prophylaxis of cytomegalovirus reactivation or disease in people with seropositive-cytomegalovirus who have had an allogeneic haematopoietic stem cell transplant
Hodgson, R., O'Connor, J., Walton, M. J., Biswas, M. & Woolacott, N. F., 31 Jul 2019, National Institute for Health and Care Excellence.Research output: Book/Report › Commissioned report
-
2018
Ceritinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer
Claxton, L., Woolacott, N. F., O'Connor, J., Wright, K. & Hodgson, R., 24 Jan 2018, National Institute for Health and Care Excellence.Research output: Book/Report › Commissioned report
-
2011
Fingolimod for the treatment of relapsing remitting multiple sclerosis
CRD and CHE Technology Assessment Group, Asaria, M., Norman, G., Hinde, S., O'Connor, J., Palmer, S. J., Light, K., O Soares, M. & Eastwood, A. J., Jun 2011, Centre for Reviews and Dissemination/ Centre for Health Economics.Research output: Book/Report › Commissioned report